Contribution: Industrial Research Assistance Program – Contributions to Firms
Pathway Rx Inc.
$75,000.00
Implementing Biomarkers for diagnostics and therapeutic evaluation and monitoring
FY 2024-25 · 2024-09-01
Summary
Pathway Rx is developing bioinformatics processes that allow to analyze and integrate multiple sources of information – genomics, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics. The outcome will be the diagnostic and therapeutic efficiency software, allowing biomarkers-based diagnosis of various conditions and the ability to monitor the efficiency of treatments.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
725412480
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-09-01 | 2024-25 | $75,000.00 |
| 1 | 2024-09-01 | 2024-25 | $75,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 150 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 150 jours.
Agreement End Date
2025-06-30
Agreement Number
1023399
Agreement Start Date
2024-09-01
Agreement Title
Implementing Biomarkers for diagnostics and therapeutic evaluation and monitoring
Agreement Title (French)
Mise en œuvre de biomarqueurs pour le diagnostic et l’évaluation et le suivi thérapeutiques
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2025-02-13
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Pathway Rx is developing bioinformatics processes that allow to analyze and integrate multiple sources of information – genomics, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics. The outcome will be the diagnostic and therapeutic efficiency software, allowing biomarkers-based diagnosis of various conditions and the ability to monitor the efficiency of treatments.
Description (French)
Pathway Rx développe des processus bio-informatiques qui permettent d’analyser et d’intégrer de multiples sources d’information - génomique, épigénomique, transcriptomique, protéomique, métabolomique et métagénomique. Le résultat sera un logiciel de diagnostic et d’efficacité thérapeutique, permettant un diagnostic basé sur les biomarqueurs de diverses conditions et la capacité de contrôler l’efficacité des traitements.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Signal Hill
Federal Riding (French)
Calgary Signal Hill
Federal Riding Number
48012
NAICS Code
62151
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
725412480
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Pathway Rx Inc.
Recipient Postal Code
T3H 4Z2
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2024-2025-Q3-1023399
